The pathogenicity of islet‐infiltrating lymphocytes in the non‐obese diabetic (NOD) mouse
暂无分享,去创建一个
[1] Irun R Cohen,et al. Hsp60 Peptide Therapy of NOD Mouse Diabetes Induces a Th2 Cytokine Burst and Downregulates Autoimmunity to Various β-Cell Antigens , 1997, Diabetes.
[2] E. Leiter,et al. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. , 1997, Journal of immunology.
[3] Xiaojian Huang,et al. Genetic Absence of γ-Interferon Delays but Does Not Prevent Diabetes in NOD Mice , 1996, Diabetes.
[4] J. Peterson,et al. Transfer of Diabetes in the NOD-scid Mouse by CD4 T-Cell Clones: Differential Requirement for CD8 T-Cells , 1996, Diabetes.
[5] C. Fathman,et al. Pathogenic and Protective Roles of CD45RBlow CD4+ Cells Correlate With Cytokine Profiles in the Spontaneously Autoimmune Diabetic Mouse , 1996, Diabetes.
[6] H. Weiner,et al. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. , 1995, The American journal of pathology.
[7] I. Cohen,et al. Treatment of Autoimmune Diabetes and Insulitis in NOD Mice With Heat Shock Protein 60 Peptide p277 , 1995, Diabetes.
[8] J. Bach. Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation. , 1995, Journal of autoimmunity.
[9] I. Cohen. Treatment of autoimmune disease: to activate or to deactivate? , 1995, Chemical immunology.
[10] A. Cooke,et al. In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. , 1995, The Journal of clinical investigation.
[11] W. Suarez-Pinzon,et al. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. , 1995, Journal of immunology.
[12] A. Rabinovitch. Immunoregulatory and Cytokine Imbalances in the Pathogenesis of IDDM: Therapeutic Intervention by Immunostimulation? , 1994, Diabetes.
[13] K. Lafferty,et al. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. , 1993, Journal of autoimmunity.
[14] E. Leiter,et al. Adoptive Transfer of Diabetes Into Immunodeficient NOD-scid/scid Mice: Relative Contributions of CD4+ and CD8+ T-Cells From Diabetic Versus Prediabetic NOD.NON-Thy-1a Donors , 1993, Diabetes.
[15] H. Fox,et al. Androgen treatment prevents diabetes in nonobese diabetic mice , 1992, The Journal of experimental medicine.
[16] H. Gaskins,et al. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Bach,et al. Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. , 1991, Endocrinology.
[18] I. Cohen,et al. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[19] O. Pankewycz,et al. Islet‐infiltrating T cell clones from non‐obese diabetic mice that promote or prevent accelerated onset diabetes , 1991, European journal of immunology.
[20] P. Bedossa,et al. Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. , 1991, Journal of autoimmunity.
[21] A. Baxter,et al. Comparison of High— and Low—Diabetes-Incidence NOD Mouse Strains , 1989, Diabetes.
[22] A. Baxter,et al. Comparison of high and low diabetes incidence non-obese diabetic mouse strains , 1989 .
[23] C. Boitard,et al. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice , 1989, The Journal of experimental medicine.
[24] Th. Mandel,et al. Progression From Insulitis to β-Cell Destruction in NOD Mouse Requires L3T4+ T-Lymphocytes , 1988, Diabetes.
[25] J. Bach,et al. Anti‐suppressor effect of cyclophosphamide on the development of spontaneous diabetes in nod mice , 1988, European journal of immunology.
[26] L. Wicker,et al. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. , 1988, Journal of immunology.
[27] A. Rabinovitch,et al. Destruction of Rat Islet Cell Monolayers by Cytokines: Synergistic Interactions of Interferon-γ, Tumor Necrosis Factor, Lymphotoxin, and Interleukin 1 , 1988, Diabetes.
[28] C. Boitard,et al. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells , 1987, The Journal of experimental medicine.
[29] D. Greiner,et al. Depletion of RT6.1+ T lymphocytes induces diabetes in resistant biobreeding/Worcester (BB/W) rats , 1987, The Journal of experimental medicine.
[30] P. Holt,et al. The ELISA-plaque assay for the detection and enumeration of antibody-secreting cells. An overview. , 1986, Journal of immunological methods.
[31] A. Monaco,et al. An improved method for isolation of mouse pancreatic islets. , 1985, Transplantation.
[32] B. Woda,et al. Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat. , 1984, The Journal of clinical investigation.
[33] B. Haynes,et al. The BB Diabetic Rat: Profound T-Cell Lymphocytopenia , 1981, Diabetes.
[34] Y. Tochino,et al. Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.
[35] W. Gepts. Pathologic Anatomy of the Pancreas in Juvenile Diabetes Mellitus , 1965, Diabetes.